Su, Enming Joseph
Cao, Chunzhang
Fredriksson, Linda
Nilsson, Ingrid
Stefanitsch, Christina
Stevenson, Tamara K.
Zhao, Juanjuan
Ragsdale, Margret
Sun, Yu-Yo
Yepes, Manuel
Kuan, Chia-Yi
Eriksson, Ulf
Strickland, Dudley K.
Lawrence, Daniel A. http://orcid.org/0000-0003-3126-1935
Zhang, Li
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL-055374, HL-054710, HL-114379, HL-120388, HL-054710, HL-054710)
National Institute of Neurological Disorders and Stroke (NS-079639, NS-082607)
Novo Nordisk Foundation
Swedish Research Council (2011-3861)
Cancerfonden (2014/630)
Hjärt-Lungfonden (2012-0077)
Article History
Received: 6 January 2017
Revised: 7 July 2017
Accepted: 10 July 2017
First Online: 19 July 2017
Compliance with ethical standards
:
: The authors have declared that that Eriksson, Lawrence, Su, Strickland, Yepes, and Fredriksson hold two patents related to this work, US 8,765,671 and US 8,147,828, entitled “Methods and compositions for modulation of blood neural barrier”.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.